Skip to main content
. 2021 Apr 9;100(14):e24654. doi: 10.1097/MD.0000000000024654

Table 1.

Population baseline characteristics.

Total (n = 174) Adherent (n = 104) Nonadherent (n = 70) P value1
Gender: Male/Females (N) 91/83 60/44 31/39 .08
SBP (mm Hg) 170 ± 27 164 ± 25 179 ± 25 <.001
DBP (mm Hg) 97 ± 18 92 ± 17 103 ± 18 <.001
Age (yr) 56 ± 14 56 ± 16 56 ± 13 .9
Number of AHT medications 4 (1–9) 4 (1–6) 5 (1–9) <.001
Number of non-AHT medications 3 (0–20) 3 (0–12) 4 (0–20) <.001
Total number of medications 7 (1–24) 6 (1–15) 9 (2–24) <.001
Comorbidities n (%)
Obesity 93 (53.4) 59 (56.7) 34 (48.6) .27
Cardiovascular disease2 82 (47.1) 44 (42.3) 38 (54.3) .16
Dyslipidaemia 67 (38.5) 39 (37.5) 28 (40.0) .39
Diabetes 34 (19.5) 17 (16.3) 17 (24.3) .23
Depression, depression or MHD 33 (19.0) 19 (18.3) 14 (20.0) .23
CKD or other renal pathology 27 (15.5) 21 (20.2) 6 (8.6) .08
Cancer 8 (4.6) 6 (5.8) 2 (3.0) .23
Liver disease 4 (2.3) 1 (1.0) 3 (4.3) .16

Data are means ± SD for SBP, DBP and age. Data are mean (range) for number of medications. SBP indicates systolic blood pressure; AHT = antihypertensive, CKD = chronic kidney disease, DBP = diastolic blood pressure, MHD = mental health disorder.

1t-test or chi square

2Cardiovascular disease refers to any pathology of the heart or blood vessels. This includes stroke, heart failure, arrhythmia, valvular heart disease and peripheral artery disease.